Sphenopalatine Ganglion Block for Headache After Concussion

Summary

This clinical trial will enroll participants to evaluate the effects of SPG block on post-traumatic headache. The study hypothesizes that patients that receive a SPG block with lidocaine vs. placebo (saline) will have a lower number of headache days in the week following the procedure, and will also report lower symptom scores. Eligible participants will receive one treatment (SPG block) as well as complete surveys prior to and after receiving treatment (for a total of approximately 2 weeks).

Timeline

Start

2021-03-18

Primary completion

2021-04-01

Completion

2021-04-06

Outcome

Outcome not reported

Stopped: “Reassignment of PI to more intense clinical obligations prevents continuation of the trial.”

Drugs

Indications